Clinical Trials

New Search
Title   A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Full Title   A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Disease/Condition   Pediatric Endocrinology
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal┬áInvestigator   Rubina Heptulla
Contact┬áName   Ranjitha Katikaneni
Contact Email   rkatikan@montefiore.org
Protocol┬áNumber   IRB# 15-02-257-01
Inclusion/Notes   This information was obtained from ClinicalTrials.gov.
Status   Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   No
Adult, Pediatric, Both   Adult